The vast majority of studies have shown that the high expression of CUL7 mainly affects the E3 ubiquitin pathway by forming Cullin (CUL)-RING E3 ubiquitin ligase (CRL), inhibiting the expression of cyclins, thereby promoting the proliferation of cancer cells and reducing apoptosis (17, 29, 30). The gene discussed is CUL7; the disease is cancer.